Publications Database

Erickson C. A. et al. (2011)

A prospective open-label study of aripiprazole in fragile X syndrome.

Psychopharmacology (Berl)

July, 216(1), pp. 85-89.

Read Abstract (New Window)

Erickson C. A. et al. (2007)

A retrospective study of memantine in children and adolescents with pervasive developmental disorders.

Psychopharmacology (Berl)

191(1), pp. 141-147

Read Abstract (New Window)

Erickson C. A. et al. (2011)

An open-label naturalistic pilot study of acamprosate in youth with autistic disorder

Journal of Child and Adolescent Psychopharmacology

Read Abstract (New Window)

Erickson C. A. et al. (2010)

Aripiprazole in autism spectrum disorders and fragile X syndrome.

Neurotherapeutics

7(3), pp. 258-263

Read Abstract (New Window)

Erickson C. A. , Mullett J. , McDougle C. J. (2010)

Brief report: acamprosate in fragile X syndrome.

Journal of Autism and Developmental Disorders

40(11), pp. 1412-1416.

Read Abstract (New Window)

Erickson C. A. et al. (2014)

Brief report: Pilot single-blind placebo lead-in study of acamprosate in youth with autistic disorder.

Journal of Autism and Developmental Disorders

April, 44(4), pp. 981-987.

Read Abstract (New Window)

Erickson C. A. et al. (2005)

Gastrointestinal factors in autistic disorder: a critical review.

Journal of Autism and Developmental Disorders

35(6), pp. 713-727

Read Abstract (New Window)

Erickson C. A. et al. (2013)

Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome.

Psychopharmacology (Berl)

July, 228(1), pp. 75-78.

Read Abstract (New Window)

Erickson C. A. , Mullett J. E. , McDougle C. J. (2009)

Open-label memantine in fragile X syndrome.

Journal of Autism and Developmental Disorders

39(12), pp. 1629-1635.

Read Abstract (New Window)

Farmer C. A. et al. (2012)

Predictors and moderators of parent training efficacy in a sample of children with autism spectrum disorders and serious behavioral problems.

Journal of Autism and Developmental Disorders

June, 4(6), pp. 1037-1044.

Read Abstract (New Window)

Hazen E. P. et al. (2014)

Sensory symptoms in autism spectrum disorders.

Harvard Review of Psychiatry

22(2), pp. 112-24.

Read Abstract (New Window)

Jahromi L. B. et al. (2009)

Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity.

Journal of Autism and Developmental Disorders

39(3), pp. 395-404

Read Abstract (New Window)

Klaeger D. , McDougle C. J. (2000)

Secretin in autism— a parent’s perspective.

Journal of Autism and Developmental Disorders

30(1), pp. 72-73.

Kowalski J. et al. (2011)

Paliperidone palmitate in a child with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

October, 21(5), pp. 491-493

Lindsay R. L. et al. (2006)

Dietary status and impact of risperidone on nutritional balance in children with autism: A pilot study.

Journal of Intellectual and Developmental Disability

December, 31(4), pp. 204-209.

Read Abstract (New Window)

Martin A. et al. (2004)

Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data.

American Journal of Psychiatry

161(6), pp. 1125-1127

Read Abstract (New Window) Read Full (New Window)

McCracken J. T. et al. (2014)

Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders.

Pharmacogenomics

14(3), pp. 295-302.

Read Abstract (New Window) Read Full (New Window)

McCracken J. T. et al. (2002)

Risperidone in children with autism and serious behavioral problems.

New England Journal of Medicine

347(5), pp. 314-321

Read Abstract (New Window) Read Full (New Window)

McDougle C. J. et al. (1998)

A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders.

Archives of General Psychiatry

55(7), pp. 633-641

Read Abstract (New Window) Read Full (New Window)

McDougle C. J. et al. (2008)

Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.

Journal of Clinical Psychiatry

69 pp.15-20

Read Abstract (New Window)